Latest Non Dilutive Funding News

Recce Pharmaceuticals has received a significant A$3.7 million income tax refund from the Australian Taxation Office, strengthening its cash position to approximately A$33.1 million as it prepares for critical Phase 3 clinical milestones.

IRIS Metals posted a $22.3 million loss for FY26, driven by major impairments on exploration assets and elevated share-based payments. The company pivots away from Edison and Tin Mountain projects, focusing on lithium-rubidium in South Dakota and tungsten in Montana.

BCAL Diagnostics has locked in an additional $4.9 million under its existing convertible note facility alongside a $1.4 million R&D tax offset tranche, reinforcing its funding runway into FY2027 for early cancer detection test development.

Nexsen has locked in over $1.5 million in non-dilutive funding through a national research partnership, accelerating manufacturing scale-up and platform optimisation for its rapid diagnostics technology.

Alliance Nickel has pushed out the maturity of its unsecured loans by a year to June 2027, increasing the interest rate from 12% to 13%. This move provides ongoing funding as the company advances strategic discussions around its NiWest nickel-cobalt project.

Everest Metals Corporation (ASX: EMC) has completed a 3,078m grade control drilling program at its Mt Dimer Taipan Gold Project, delivering multiple high-grade gold intersections and advancing mining operations ahead of a resource update targeted for Q3 2026.

Tungsten Mining NL's Watershed Preliminary Economic Evaluation reveals a robust project with a pre-tax NPV of A$1.3 billion and a swift payback, aiming for first production by 2027 amid tightening global tungsten supply.

Critica Limited is progressing its Jupiter and Mt Lindsay projects with key resource updates, metallurgical breakthroughs, and strategic partnerships, targeting Scoping Study completion in Q3 2026.

Nexalis Therapeutics has locked in a $53 million non-dilutive funding facility with Point8 Capital, replacing its previous lender and supporting three clinical programs targeting breakthrough cancer pain, panic disorder, and treatment-resistant depression.

Blackpearl Group has posted a record 114% jump in Annual Recurring Revenue to NZD 26.8 million, powered by its Pearl Engine vertical AI model that benchmarks 25 times better than leading generalist AI. Despite deepening losses, the firm targets balanced growth and cash conversion in FY27.

Redcastle Resources has launched continuous mining at its Redcastle Reef gold deposit, advancing from exploration to production under a capital-light joint venture with BML Ventures. Ore haulage to third-party processing is scheduled to begin in June 2026, with first toll treatment expected in July.

HIQ Limited has locked in non-dilutive funding from the Victorian Government to underpin a $4.9 million project expanding its manufacturing and research footprint in Victoria, supporting its global growth ambitions.